Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
American Association for the Advancement of Science (AAAS) awards the distinction to noted researcher Guillermo Oliver, Ph.D., for his work in developmental biology
Study of gene therapy developed at St. Jude Children’s Research Hospital and University College London offers first proof that the treatment benefits adults with hemophilia B; reduces need for clotting factor to prevent bleeds.
St. Jude Children’s Research Hospital scientists show that a gene essential for normal development of the lymphatic system also plays a critical role in forming the valves that help maintain the body’s normal fluid balance.
St. Jude Children’s Research Hospital scientists discover that a post-production addition to most proteins can serve as a key to mediate protein interactions, which are at the foundation of life.
A small molecule developed at St. Jude Children’s Research Hospital advances progress toward more tailored drugs in research that also offers insight into the biology of thyroid hormone.
Recently approved drug for treatment of an adult cancer is the latest example of how St. Jude scientific discoveries are used to identify new therapies that benefit patients regardless of age
St. Jude Children’s Research Hospital nurse Jody Newell is a semi-finalist in The “Amazing Nurses” Contest: Celebrating America’s Caregivers. Chosen from 1,500 nominations nationwide, Newell is one of only 20 semi-finalists.
St. Jude Children’s Research Hospital scientists tie low levels of a key DNA repair protein to loss of regulatory genes in a study that offers new clues about why acute lymphoblastic leukemia sometimes returns.
Study led by St. Jude Children’s Research Hospital scientists points to possible new treatment targets for diffuse intrinsic pontine gliomas; may tip the scales in the current debate about tumor biopsies.
The Know Your Sickle Status program, spearheaded by St. Jude Children’s Research Hospital, works with community partners to educate families on trait status for genetic disorder
Research led by St. Jude Children’s Research Hospital investigators used a pioneering approach to drug development and identified dozens of potential new treatments of ependymoma, a rare tumor of the brain and spinal cord.
St. Jude Children’s Research Hospital recognizes Childhood Cancer Awareness Month
Noted researcher will direct the country's only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children.
St. Jude Children’s Research Hospital scientists lead research that settles a century-old debate about retinoblastoma’s beginnings and identify new targets for treating the childhood eye tumor
St. Jude Children’s Research Hospital scientists show that the molecule serves as a bridge between the two arms of the immune system that provides a new mechanism guiding T cell differentiation
St. Jude Children’s Research Hospital scientists provide insight into immune system biology and identify the mechanism that keeps white blood cell activity at a minimum until the specific immune response is needed.
St. Jude Children’s Research Hospital investigators reported markedly improved survival of pediatric patients transplanted for high-risk leukemia regardless of donor; cite treatment advances and better donor selection.
St. Jude Children’s Research Hospital oncologist Ching-Hon Pui is the recipient of the 2011 Henry M. Stratton Medal for work that has advanced the research and treatment of pediatric leukemia
The Scientist magazine ranks St. Jude Children's Research Hospital among the top 10
Findings from the Childhood Cancer Survivor Study led by St. Jude Children’s Research Hospital investigators identify new cancer risks when survivors become adults; underscore the importance of regular cancer screenings
St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project scientists pioneer way to find more chromosomal aberrations in tumors; results likely to advance understanding of cancer
St. Jude Children’s Research Hospital scientist recognized with the Dorothy Crowfoot Hodgkin Award from The Protein Society
The multicenter Baby HUG trial led by St. Jude Children’s Research Hospital investigators shows hydroxyurea reduces the most common symptoms of sickle cell anemia in children, raising hopes the drug will ease complications and improve patient quality of life.
Thought leaders worldwide will convene at the Cure4Kids Global Summit to discuss ways of improving science and health education in schools and communities with a focus on disease prevention in children.
Martine Roussel, Ph.D., of St. Jude Children’s Research Hospital, has been named to the 2011 class of new Fellows and Foreign Honorary Members of the American Academy of Arts and Sciences.
A national Childhood Cancer Survivor Study led by St. Jude Children’s Research Hospital investigators identifies potential new strategies for helping adults who survived childhood cancer improve memory, attention and related skills.
Kimberly Ovitt hired to take the helm of the hospital’s public relations and communication efforts.
St. Jude Children’s Research Hospital physician receives the Paul P. Carbone Award in International Oncology from the International Network for Cancer Treatment and Research for his efforts to improve childhood cancer survival rates across the globe.
St. Jude Children’s Research Hospital pediatric oncologist Ching-Hon Pui, M.D., is the recipient of the 2011 Annual AACR Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Research for contributions to childhood cancer research and treatment.
St. Jude Children’s Research Hospital investigators use a novel model system to show how specific mutations can induce glioma formation in multiple regions of the brain and to begin studying patient response to a new generation of targeted therapies.
The effort led by St. Jude Children’s Research Hospital scientists identified the gene as a potential marker of relapse risk and involved the most comprehensive search yet for genomic changes in relapsed childhood acute lymphoblastic leukemia
Work led by St. Jude Children’s Research Hospital investigators provides fresh insight into mechanisms controlling programmed cell death pathways and offers new targets in the fight against cancer and virus-infected cells.
New research from St. Jude Children’s Research Hospital and the Children’s Oncology Group ties the genetic variation characteristic of Native American ancestry to higher odds cancer will return and highlights a strategy to ease the racial disparities in survival.
St. Jude Children’s Research Hospital has been recognized by FORTUNE magazine as one of the “100 Best Companies to Work For.” This is the first year St. Jude has been included in the publication’s annual list.